Pediatric deep neck infections: Clinical description and analysis of therapeutic management.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 13 11 2020
revised: 20 10 2021
accepted: 30 11 2021
pubmed: 28 12 2021
medline: 8 2 2022
entrez: 27 12 2021
Statut: ppublish

Résumé

The aim of our study was to describe clinical presentations, bacteriological results, and therapeutic management in a pediatric population presenting with acute pharyngeal suppuration. A further aim was to identify clinical, bacteriological, and radiological predictors of success associated with exclusive medical treatment. A retrospective study was carried out including patients under 18 years of age hospitalized between January 1, 2015 and December 31, 2017 in our center for acute pharyngeal suppuration. We identified three groups of patients: group A, treated with exclusive intravenous antibiotics; group B, surgically treated after 48 h of appropriate antibiotic therapy, due to persistent fever and/or clinical worsening and/or persistence of a collection on follow-up imaging; group C, surgically treated as first-line therapy in association with intravenous antibiotics. A total of 83 patients were included: 36 in group A, 12 in group B, and 35 in group C. These three groups were compared for several variables: age of the patients, polynuclear neutrophil counts, diameter of the collections (the largest diameter found on imaging), duration of antibiotic therapy, delay before return to apyrexia, and hospitalization duration. A neck mass and torticollis were present, respectively, in 48.8 and 47.6% of cases. No breathing difficulties were reported. Streptococcus pyogenes was the most frequently identified microorganism. The average diameter of the collections from patients treated surgically as first-line therapy (group C) was significantly larger than that of the patients treated with antibiotics (group A) (27.89 mm vs. 18.73 mm, respectively, p = 0.0006). All the patients who required surgery despite 48 h of appropriate antibiotic therapy (group B) had collections with diameters greater than or equal to 15 mm. There was no significant difference between the groups concerning hospitalization duration. Exclusive medical treatment is associated with a high cure rate, mainly for collections with small diameter. We recommend special attention to patients treated with first-line exclusive intravenous antibiotic therapy and with a collection diameter greater than or equal to 15 mm.

Identifiants

pubmed: 34955300
pii: S0929-693X(21)00238-4
doi: 10.1016/j.arcped.2021.11.011
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-132

Informations de copyright

Copyright © 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

N Demongeot (N)

Department of Pediatrics, University Hospital Arnaud de Villeneuve, University of Montpellier, France.

M Akkari (M)

Department of Ear Nose and Throat and Head and Neck surgery, University Hospital Gui de Chauliac, 80 avenue Augustin Fliche, University of Montpellier, Montpellier 34295 Cedex 5, France. Electronic address: m-akkari@chu-montpellier.fr.

C Blanchet (C)

Department of Ear Nose and Throat and Head and Neck surgery, University Hospital Gui de Chauliac, 80 avenue Augustin Fliche, University of Montpellier, Montpellier 34295 Cedex 5, France.

S Godreuil (S)

Department of Bacteriology, University Hospital Arnaud de Villeneuve, UMR MIVEGEC, UMR IRD 224-CNRS INSERM 1058, University of Montpellier, Montpellier, France.

O Prodhomme (O)

Department of Pediatric imaging, University Hospital Arnaud de Villeneuve, University of Montpellier, France.

N Leboucq (N)

Department of Bacteriology, University Hospital Arnaud de Villeneuve, UMR MIVEGEC, UMR IRD 224-CNRS INSERM 1058, University of Montpellier, Montpellier, France.

M Mondain (M)

Department of Ear Nose and Throat and Head and Neck surgery, University Hospital Gui de Chauliac, 80 avenue Augustin Fliche, University of Montpellier, Montpellier 34295 Cedex 5, France.

E Jeziorski (E)

Department of Pediatrics, University Hospital Arnaud de Villeneuve, University of Montpellier, France; Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH